Travel habits and complications in patients treated with vitamin K antagonists: A cross sectional analysis
Summary Background Travel-related conditions have impact on the quality of oral anticoagulation therapy (OAT) with vitamin K-antagonists. No predictors for travel activity and for travel-associated haemorrhage or thromboembolic complications of patients on OAT are known. Methods A standardised quest...
Gespeichert in:
| Veröffentlicht in: | Travel medicine and infectious disease 2014-05, Vol.12 (3), p.258-263 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 263 |
|---|---|
| container_issue | 3 |
| container_start_page | 258 |
| container_title | Travel medicine and infectious disease |
| container_volume | 12 |
| creator | Ringwald, Juergen Lehmann, Marina Niemeyer, Nicole Seifert, Isabell Daubmann, Anne Wegscheider, Karl Salzwedel, Annett Luxembourg, Beate Eckstein, Reinhold Voeller, Heinz |
| description | Summary Background Travel-related conditions have impact on the quality of oral anticoagulation therapy (OAT) with vitamin K-antagonists. No predictors for travel activity and for travel-associated haemorrhage or thromboembolic complications of patients on OAT are known. Methods A standardised questionnaire was sent to 2500 patients on long-term OAT in Austria, Switzerland and Germany. 997 questionnaires were received (responder rate 39.9%). Ordinal or logistic regression models with travel activity before and after onset of OAT or travel-associated haemorrhages and thromboembolic complications as outcome measures were applied. Results 43.4% changed travel habits since onset of OAT with 24.9% and 18.5% reporting decreased or increased travel activity, respectively. Long-distance worldwide before OAT or having suffered from thromboembolic complications was associated with reduced travel activity. Increased travel activity was associated with more intensive travel experience, increased duration of OAT, higher education, or performing patient self-management (PSM). Travel-associated haemorrhages or thromboembolic complications were reported by 6.5% and 0.9% of the patients, respectively. Former thromboembolic complications, former bleedings and PSM were significant predictors of travel-associated complications. Conclusions OAT also increases travel intensity. Specific medical advice prior travelling to prevent complications should be given especially to patients with former bleedings or thromboembolic complications and to those performing PSM. |
| doi_str_mv | 10.1016/j.tmaid.2014.02.006 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1531951490</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1477893914000477</els_id><sourcerecordid>1531951490</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-3e80a23e3dd853073f111f56e3443578f818d5728e25ca985aa8eda8002f6fe13</originalsourceid><addsrcrecordid>eNqFUk1v1DAQjRCIlsIvQEKWuHBJGH8lDhKVqoovUYkD5Wy5zoQ65GOxvYv23zPZLSD1wskjzXvjN-9NUTznUHHg9euhypMLXSWAqwpEBVA_KE65aWQJSomHVKumKU0r25PiSUoDgNRGycfFiVC1bgTAaTFcR7fDkd26m5ATc3PH_DJtxuBdDsucWJjZhkqcqZsjuowd-xXyLduF7CbqfiZSdt-XOaSc3rAL5uOSEkvo1wFupLYb9ymkp8Wj3o0Jn929Z8W39--uLz-WV18-fLq8uCo9qc6lRANOSJRdZ7SERvac817XKJWSujG94aYj9QaF9q412jmDnTMAoq975PKseHWcu4nLzy2mbKeQPI6jm3HZJsu15K3mqgWCvrwHHZZtJL0HFCjQQkpCySPqsFnE3m5imFzcWw52jcIO9hCFXaOwICxFQawXd7O3NxN2fzl_vCfA2yMAyYxdwGiTJ589diGSebZbwn8-OL_H92OYKbjxB-4x_dvEJiLYr-s1rMfAFQBQLX8D4TevsQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1530405233</pqid></control><display><type>article</type><title>Travel habits and complications in patients treated with vitamin K antagonists: A cross sectional analysis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ringwald, Juergen ; Lehmann, Marina ; Niemeyer, Nicole ; Seifert, Isabell ; Daubmann, Anne ; Wegscheider, Karl ; Salzwedel, Annett ; Luxembourg, Beate ; Eckstein, Reinhold ; Voeller, Heinz</creator><creatorcontrib>Ringwald, Juergen ; Lehmann, Marina ; Niemeyer, Nicole ; Seifert, Isabell ; Daubmann, Anne ; Wegscheider, Karl ; Salzwedel, Annett ; Luxembourg, Beate ; Eckstein, Reinhold ; Voeller, Heinz</creatorcontrib><description>Summary Background Travel-related conditions have impact on the quality of oral anticoagulation therapy (OAT) with vitamin K-antagonists. No predictors for travel activity and for travel-associated haemorrhage or thromboembolic complications of patients on OAT are known. Methods A standardised questionnaire was sent to 2500 patients on long-term OAT in Austria, Switzerland and Germany. 997 questionnaires were received (responder rate 39.9%). Ordinal or logistic regression models with travel activity before and after onset of OAT or travel-associated haemorrhages and thromboembolic complications as outcome measures were applied. Results 43.4% changed travel habits since onset of OAT with 24.9% and 18.5% reporting decreased or increased travel activity, respectively. Long-distance worldwide before OAT or having suffered from thromboembolic complications was associated with reduced travel activity. Increased travel activity was associated with more intensive travel experience, increased duration of OAT, higher education, or performing patient self-management (PSM). Travel-associated haemorrhages or thromboembolic complications were reported by 6.5% and 0.9% of the patients, respectively. Former thromboembolic complications, former bleedings and PSM were significant predictors of travel-associated complications. Conclusions OAT also increases travel intensity. Specific medical advice prior travelling to prevent complications should be given especially to patients with former bleedings or thromboembolic complications and to those performing PSM.</description><identifier>ISSN: 1477-8939</identifier><identifier>EISSN: 1873-0442</identifier><identifier>DOI: 10.1016/j.tmaid.2014.02.006</identifier><identifier>PMID: 24657200</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Anticoagulants ; Anticoagulants - administration & dosage ; Anticoagulants - adverse effects ; Austria ; Cardiac arrhythmia ; Confidence intervals ; Cross-Sectional Studies ; Female ; Germany ; Habits ; Hemorrhage - etiology ; Hospitals ; Humans ; Infectious Disease ; Male ; Marital status ; Middle Aged ; Multivariate analysis ; Oral anticoagulation ; Patient self-management ; Patients ; Self Care ; Studies ; Surveys and Questionnaires ; Switzerland ; Thromboembolism - etiology ; Thrombosis ; Travel ; Travel Medicine ; Values ; Vitamin K - antagonists & inhibitors ; Vitamin K-antagonists ; Young Adult</subject><ispartof>Travel medicine and infectious disease, 2014-05, Vol.12 (3), p.258-263</ispartof><rights>Elsevier Ltd</rights><rights>2014 Elsevier Ltd</rights><rights>Copyright © 2014 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited May 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-3e80a23e3dd853073f111f56e3443578f818d5728e25ca985aa8eda8002f6fe13</citedby><cites>FETCH-LOGICAL-c442t-3e80a23e3dd853073f111f56e3443578f818d5728e25ca985aa8eda8002f6fe13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1477893914000477$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24657200$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ringwald, Juergen</creatorcontrib><creatorcontrib>Lehmann, Marina</creatorcontrib><creatorcontrib>Niemeyer, Nicole</creatorcontrib><creatorcontrib>Seifert, Isabell</creatorcontrib><creatorcontrib>Daubmann, Anne</creatorcontrib><creatorcontrib>Wegscheider, Karl</creatorcontrib><creatorcontrib>Salzwedel, Annett</creatorcontrib><creatorcontrib>Luxembourg, Beate</creatorcontrib><creatorcontrib>Eckstein, Reinhold</creatorcontrib><creatorcontrib>Voeller, Heinz</creatorcontrib><title>Travel habits and complications in patients treated with vitamin K antagonists: A cross sectional analysis</title><title>Travel medicine and infectious disease</title><addtitle>Travel Med Infect Dis</addtitle><description>Summary Background Travel-related conditions have impact on the quality of oral anticoagulation therapy (OAT) with vitamin K-antagonists. No predictors for travel activity and for travel-associated haemorrhage or thromboembolic complications of patients on OAT are known. Methods A standardised questionnaire was sent to 2500 patients on long-term OAT in Austria, Switzerland and Germany. 997 questionnaires were received (responder rate 39.9%). Ordinal or logistic regression models with travel activity before and after onset of OAT or travel-associated haemorrhages and thromboembolic complications as outcome measures were applied. Results 43.4% changed travel habits since onset of OAT with 24.9% and 18.5% reporting decreased or increased travel activity, respectively. Long-distance worldwide before OAT or having suffered from thromboembolic complications was associated with reduced travel activity. Increased travel activity was associated with more intensive travel experience, increased duration of OAT, higher education, or performing patient self-management (PSM). Travel-associated haemorrhages or thromboembolic complications were reported by 6.5% and 0.9% of the patients, respectively. Former thromboembolic complications, former bleedings and PSM were significant predictors of travel-associated complications. Conclusions OAT also increases travel intensity. Specific medical advice prior travelling to prevent complications should be given especially to patients with former bleedings or thromboembolic complications and to those performing PSM.</description><subject>Administration, Oral</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anticoagulants</subject><subject>Anticoagulants - administration & dosage</subject><subject>Anticoagulants - adverse effects</subject><subject>Austria</subject><subject>Cardiac arrhythmia</subject><subject>Confidence intervals</subject><subject>Cross-Sectional Studies</subject><subject>Female</subject><subject>Germany</subject><subject>Habits</subject><subject>Hemorrhage - etiology</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Infectious Disease</subject><subject>Male</subject><subject>Marital status</subject><subject>Middle Aged</subject><subject>Multivariate analysis</subject><subject>Oral anticoagulation</subject><subject>Patient self-management</subject><subject>Patients</subject><subject>Self Care</subject><subject>Studies</subject><subject>Surveys and Questionnaires</subject><subject>Switzerland</subject><subject>Thromboembolism - etiology</subject><subject>Thrombosis</subject><subject>Travel</subject><subject>Travel Medicine</subject><subject>Values</subject><subject>Vitamin K - antagonists & inhibitors</subject><subject>Vitamin K-antagonists</subject><subject>Young Adult</subject><issn>1477-8939</issn><issn>1873-0442</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFUk1v1DAQjRCIlsIvQEKWuHBJGH8lDhKVqoovUYkD5Wy5zoQ65GOxvYv23zPZLSD1wskjzXvjN-9NUTznUHHg9euhypMLXSWAqwpEBVA_KE65aWQJSomHVKumKU0r25PiSUoDgNRGycfFiVC1bgTAaTFcR7fDkd26m5ATc3PH_DJtxuBdDsucWJjZhkqcqZsjuowd-xXyLduF7CbqfiZSdt-XOaSc3rAL5uOSEkvo1wFupLYb9ymkp8Wj3o0Jn929Z8W39--uLz-WV18-fLq8uCo9qc6lRANOSJRdZ7SERvac817XKJWSujG94aYj9QaF9q412jmDnTMAoq975PKseHWcu4nLzy2mbKeQPI6jm3HZJsu15K3mqgWCvrwHHZZtJL0HFCjQQkpCySPqsFnE3m5imFzcWw52jcIO9hCFXaOwICxFQawXd7O3NxN2fzl_vCfA2yMAyYxdwGiTJ589diGSebZbwn8-OL_H92OYKbjxB-4x_dvEJiLYr-s1rMfAFQBQLX8D4TevsQ</recordid><startdate>20140501</startdate><enddate>20140501</enddate><creator>Ringwald, Juergen</creator><creator>Lehmann, Marina</creator><creator>Niemeyer, Nicole</creator><creator>Seifert, Isabell</creator><creator>Daubmann, Anne</creator><creator>Wegscheider, Karl</creator><creator>Salzwedel, Annett</creator><creator>Luxembourg, Beate</creator><creator>Eckstein, Reinhold</creator><creator>Voeller, Heinz</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>F1W</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H95</scope><scope>H97</scope><scope>K9.</scope><scope>KB0</scope><scope>L.G</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20140501</creationdate><title>Travel habits and complications in patients treated with vitamin K antagonists: A cross sectional analysis</title><author>Ringwald, Juergen ; Lehmann, Marina ; Niemeyer, Nicole ; Seifert, Isabell ; Daubmann, Anne ; Wegscheider, Karl ; Salzwedel, Annett ; Luxembourg, Beate ; Eckstein, Reinhold ; Voeller, Heinz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-3e80a23e3dd853073f111f56e3443578f818d5728e25ca985aa8eda8002f6fe13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Administration, Oral</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anticoagulants</topic><topic>Anticoagulants - administration & dosage</topic><topic>Anticoagulants - adverse effects</topic><topic>Austria</topic><topic>Cardiac arrhythmia</topic><topic>Confidence intervals</topic><topic>Cross-Sectional Studies</topic><topic>Female</topic><topic>Germany</topic><topic>Habits</topic><topic>Hemorrhage - etiology</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Infectious Disease</topic><topic>Male</topic><topic>Marital status</topic><topic>Middle Aged</topic><topic>Multivariate analysis</topic><topic>Oral anticoagulation</topic><topic>Patient self-management</topic><topic>Patients</topic><topic>Self Care</topic><topic>Studies</topic><topic>Surveys and Questionnaires</topic><topic>Switzerland</topic><topic>Thromboembolism - etiology</topic><topic>Thrombosis</topic><topic>Travel</topic><topic>Travel Medicine</topic><topic>Values</topic><topic>Vitamin K - antagonists & inhibitors</topic><topic>Vitamin K-antagonists</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ringwald, Juergen</creatorcontrib><creatorcontrib>Lehmann, Marina</creatorcontrib><creatorcontrib>Niemeyer, Nicole</creatorcontrib><creatorcontrib>Seifert, Isabell</creatorcontrib><creatorcontrib>Daubmann, Anne</creatorcontrib><creatorcontrib>Wegscheider, Karl</creatorcontrib><creatorcontrib>Salzwedel, Annett</creatorcontrib><creatorcontrib>Luxembourg, Beate</creatorcontrib><creatorcontrib>Eckstein, Reinhold</creatorcontrib><creatorcontrib>Voeller, Heinz</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Professional</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Travel medicine and infectious disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ringwald, Juergen</au><au>Lehmann, Marina</au><au>Niemeyer, Nicole</au><au>Seifert, Isabell</au><au>Daubmann, Anne</au><au>Wegscheider, Karl</au><au>Salzwedel, Annett</au><au>Luxembourg, Beate</au><au>Eckstein, Reinhold</au><au>Voeller, Heinz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Travel habits and complications in patients treated with vitamin K antagonists: A cross sectional analysis</atitle><jtitle>Travel medicine and infectious disease</jtitle><addtitle>Travel Med Infect Dis</addtitle><date>2014-05-01</date><risdate>2014</risdate><volume>12</volume><issue>3</issue><spage>258</spage><epage>263</epage><pages>258-263</pages><issn>1477-8939</issn><eissn>1873-0442</eissn><abstract>Summary Background Travel-related conditions have impact on the quality of oral anticoagulation therapy (OAT) with vitamin K-antagonists. No predictors for travel activity and for travel-associated haemorrhage or thromboembolic complications of patients on OAT are known. Methods A standardised questionnaire was sent to 2500 patients on long-term OAT in Austria, Switzerland and Germany. 997 questionnaires were received (responder rate 39.9%). Ordinal or logistic regression models with travel activity before and after onset of OAT or travel-associated haemorrhages and thromboembolic complications as outcome measures were applied. Results 43.4% changed travel habits since onset of OAT with 24.9% and 18.5% reporting decreased or increased travel activity, respectively. Long-distance worldwide before OAT or having suffered from thromboembolic complications was associated with reduced travel activity. Increased travel activity was associated with more intensive travel experience, increased duration of OAT, higher education, or performing patient self-management (PSM). Travel-associated haemorrhages or thromboembolic complications were reported by 6.5% and 0.9% of the patients, respectively. Former thromboembolic complications, former bleedings and PSM were significant predictors of travel-associated complications. Conclusions OAT also increases travel intensity. Specific medical advice prior travelling to prevent complications should be given especially to patients with former bleedings or thromboembolic complications and to those performing PSM.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>24657200</pmid><doi>10.1016/j.tmaid.2014.02.006</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1477-8939 |
| ispartof | Travel medicine and infectious disease, 2014-05, Vol.12 (3), p.258-263 |
| issn | 1477-8939 1873-0442 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1531951490 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Administration, Oral Adult Aged Aged, 80 and over Anticoagulants Anticoagulants - administration & dosage Anticoagulants - adverse effects Austria Cardiac arrhythmia Confidence intervals Cross-Sectional Studies Female Germany Habits Hemorrhage - etiology Hospitals Humans Infectious Disease Male Marital status Middle Aged Multivariate analysis Oral anticoagulation Patient self-management Patients Self Care Studies Surveys and Questionnaires Switzerland Thromboembolism - etiology Thrombosis Travel Travel Medicine Values Vitamin K - antagonists & inhibitors Vitamin K-antagonists Young Adult |
| title | Travel habits and complications in patients treated with vitamin K antagonists: A cross sectional analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T06%3A26%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Travel%20habits%20and%20complications%20in%20patients%20treated%20with%20vitamin%20K%20antagonists:%20A%20cross%20sectional%20analysis&rft.jtitle=Travel%20medicine%20and%20infectious%20disease&rft.au=Ringwald,%20Juergen&rft.date=2014-05-01&rft.volume=12&rft.issue=3&rft.spage=258&rft.epage=263&rft.pages=258-263&rft.issn=1477-8939&rft.eissn=1873-0442&rft_id=info:doi/10.1016/j.tmaid.2014.02.006&rft_dat=%3Cproquest_cross%3E1531951490%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1530405233&rft_id=info:pmid/24657200&rft_els_id=1_s2_0_S1477893914000477&rfr_iscdi=true |